Synovial Fibroblast 3.2: Secretion response of seven primary human synovial fibroblast samples from healthy and rheumatoid arthritis-diagnosed donors to a panel of 3 stimuli and 5 small molecule inhibitors (replicate 2 of 2) - Dataset (ID:20235)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
0 | MCP-1 (MCAF) | 16.5 | 30 | ||||||||
0 | MCP-1 (MCAF) | 17.0 | 49 | ||||||||
RA2159 | 5z-7-oxozeaenol | 0.6 | uM | 4 | MCP-1 (MCAF) | 133.0 | 51 | ||||
RA2159 | IKK16 | 2.0 | uM | 4 | MCP-1 (MCAF) | 175.0 | 45 | ||||
N2645 | 5z-7-oxozeaenol | 0.6 | uM | 4 | MCP-1 (MCAF) | 204.0 | 50 | ||||
N2645 | IKK16 | 2.0 | uM | 4 | MCP-1 (MCAF) | 172.0 | 52 | ||||
RA2708 | 5z-7-oxozeaenol | 0.6 | uM | 4 | MCP-1 (MCAF) | 155.0 | 49 | ||||
RA2708 | IKK16 | 2.0 | uM | 4 | MCP-1 (MCAF) | 90.0 | 63 | ||||
RA2159 | Tofacitinib | 0.3 | uM | 4 | MCP-1 (MCAF) | 153.5 | 52 | ||||
RA2159 | 4 | MCP-1 (MCAF) | 188.0 | 34 | |||||||
N2645 | Tofacitinib | 0.3 | uM | 4 | MCP-1 (MCAF) | 269.5 | 50 | ||||
N2645 | 4 | MCP-1 (MCAF) | 331.0 | 52 | |||||||
RA2708 | Tofacitinib | 0.3 | uM | 4 | MCP-1 (MCAF) | 140.0 | 47 | ||||
RA2708 | 4 | MCP-1 (MCAF) | 85.0 | 43 | |||||||
RA2159 | 5z-7-oxozeaenol | 0.6 | uM | Poly(I:C) | 2 | ug/mL | 4 | MCP-1 (MCAF) | 249.0 | 45 | |
RA2159 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 4 | MCP-1 (MCAF) | 1405.0 | 49 | |
N2645 | 5z-7-oxozeaenol | 0.6 | uM | Poly(I:C) | 2 | ug/mL | 4 | MCP-1 (MCAF) | 670.0 | 55 | |
N2645 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 4 | MCP-1 (MCAF) | 1201.5 | 66 | |
RA2708 | 5z-7-oxozeaenol | 0.6 | uM | Poly(I:C) | 2 | ug/mL | 4 | MCP-1 (MCAF) | 423.0 | 41 | |
RA2708 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 4 | MCP-1 (MCAF) | 553.0 | 46 | |
RA2159 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 4 | MCP-1 (MCAF) | 3412.0 | 38 | |
RA2159 | Poly(I:C) | 2 | ug/mL | 4 | MCP-1 (MCAF) | 5476.0 | 49 | ||||
N2645 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 4 | MCP-1 (MCAF) | 5899.0 | 39 | |
N2645 | Poly(I:C) | 2 | ug/mL | 4 | MCP-1 (MCAF) | 7275.0 | 43 | ||||
RA2708 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 4 | MCP-1 (MCAF) | 5059.0 | 41 |